near-significantP = 0.056
Bcl I carriers treated with GC had a near-significant lower AUC of DAS28 postpartum compared with noncarriers ( P = 0.056; Figure 2B , right panel).
Bcl I carriers treated with GC had a near-significant lower AUC of DAS28 postpartum compared with noncarriers ( P = 0.056; Figure 2B , right panel).